Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

Fox CB, Baldwin SL, Duthie MS, Reed SG, Vedvick TS.

AAPS PharmSciTech. 2012 Jun;13(2):498-506. doi: 10.1208/s12249-012-9771-x. Epub 2012 Mar 14.

2.

Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions.

Fox CB, Lin S, Sivananthan SJ, Dutill TS, Forseth KT, Reed SG, Vedvick TS.

Pharm Dev Technol. 2011 Oct;16(5):511-9. doi: 10.3109/10837450.2010.495397. Epub 2010 Jun 16.

PMID:
20550484
3.

A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.

Deng J, Cai W, Jin F.

Int J Pharm. 2014 Jul 1;468(1-2):187-95. doi: 10.1016/j.ijpharm.2014.04.003. Epub 2014 Apr 4.

PMID:
24704309
4.

The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.

Shah RR, Dodd S, Schaefer M, Ugozzoli M, Singh M, Otten GR, Amiji MM, O'Hagan DT, Brito LA.

J Pharm Sci. 2015 Apr;104(4):1352-61. doi: 10.1002/jps.24337. Epub 2015 Jan 19.

PMID:
25600347
5.

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Fox CB, Baldwin SL, Duthie MS, Reed SG, Vedvick TS.

Vaccine. 2011 Nov 28;29(51):9563-72. doi: 10.1016/j.vaccine.2011.08.089. Epub 2011 Sep 9.

6.

Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.

Fox CB, Barnes V L, Evers T, Chesko JD, Vedvick TS, Coler RN, Reed SG, Baldwin SL.

Influenza Other Respir Viruses. 2013 Sep;7(5):815-26. doi: 10.1111/irv.12031. Epub 2012 Nov 5.

7.

An alternative renewable source of squalene for use in emulsion adjuvants.

Brito LA, Chan M, Baudner B, Gallorini S, Santos G, O'Hagan DT, Singh M.

Vaccine. 2011 Aug 26;29(37):6262-8. doi: 10.1016/j.vaccine.2011.06.067. Epub 2011 Jun 30.

PMID:
21723355
9.
10.

Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions.

Fox CB, Anderson RC, Dutill TS, Goto Y, Reed SG, Vedvick TS.

Colloids Surf B Biointerfaces. 2008 Aug 1;65(1):98-105. doi: 10.1016/j.colsurfb.2008.03.003. Epub 2008 Mar 22.

PMID:
18440205
11.
12.

Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.

Iyer V, Cayatte C, Guzman B, Schneider-Ohrum K, Matuszak R, Snell A, Rajani GM, McCarthy MP, Muralidhara B.

Hum Vaccin Immunother. 2015;11(7):1853-64. doi: 10.1080/21645515.2015.1046660.

14.

AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.

Klucker MF, Dalençon F, Probeck P, Haensler J.

J Pharm Sci. 2012 Dec;101(12):4490-500. doi: 10.1002/jps.23311. Epub 2012 Aug 31.

PMID:
22941944
15.

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.

Fox CB, Baldwin SL, Vedvick TS, Angov E, Reed SG.

Clin Vaccine Immunol. 2012 Oct;19(10):1633-40. Epub 2012 Aug 15.

16.

Evaluation of membrane models and their composition for islet amyloid polypeptide-membrane aggregation.

Caillon L, Lequin O, Khemtémourian L.

Biochim Biophys Acta. 2013 Sep;1828(9):2091-8. doi: 10.1016/j.bbamem.2013.05.014. Epub 2013 May 23.

17.
18.

Molecular Design of Squalene/Squalane Countertypes via the Controlled Oligomerization of Isoprene and Evaluation of Vaccine Adjuvant Applications.

Adlington K, El Harfi J, Li J, Carmichael K, Guderian JA, Fox CB, Irvine DJ.

Biomacromolecules. 2016 Jan 11;17(1):165-72. doi: 10.1021/acs.biomac.5b01285. Epub 2015 Dec 29.

PMID:
26652915
19.

Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine.

Tiwari S, Goyal AK, Mishra N, Khatri K, Vaidya B, Mehta A, Wu Y, Vyas SP.

J Control Release. 2009 Dec 3;140(2):157-65. doi: 10.1016/j.jconrel.2009.08.004. Epub 2009 Aug 15.

PMID:
19686788
20.

Development of pH responsive novel emulsion adjuvant for oral immunization and in vivo evaluation.

Malik B, Gupta RK, Rath G, Goyal AK.

Eur J Pharm Biopharm. 2014 Aug;87(3):589-97. doi: 10.1016/j.ejpb.2014.03.014. Epub 2014 Mar 27.

PMID:
24681295

Supplemental Content

Support Center